Related Experiment Videos
Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against
U Baumgartner1, J Schölmerich, M Sellinger
1Department of Surgery, University of Freiburg, Germany.
Digestive Diseases and Sciences
|February 1, 1996
Summary
Taurine conjugation of ursodeoxycholate (UDC) is crucial for preventing taurolithocholate (TLC)-induced cholestasis. Derivatives like MUDC, lacking this conjugation, offer minimal protection, highlighting the importance of taurine for bile acid therapy.
Area of Science:
- Hepatology and Gastroenterology
- Bile Acid Metabolism
- Drug Development
Background:
- Cholestasis, a liver condition, can be induced by taurolithocholate (TLC).
- Ursodeoxycholate (UDC) and its taurine conjugate (TUDC) are known to protect against cholestasis.
- The role of taurine conjugation in UDC's protective mechanism against TLC-induced cholestasis requires further investigation.
Purpose of the Study:
- To investigate the protective role of taurine conjugation in ursodeoxycholate (UDC) against taurolithocholate (TLC)-induced cholestasis.
- To compare the efficacy of tauroursodeoxycholate (TUDC) and 23-Methyl-ursodeoxycholate (MUDC) in preventing TLC-induced cholestasis.
- To determine if taurine conjugation is a prerequisite for the anticholestatic effect of UDC.
Main Methods:
- Isolated rat livers were perfused with taurolithocholate (TLC) alone or in combination with ursodeoxycholate (UDC), tauroursodeoxycholate (TUDC), or 23-Methyl-ursodeoxycholate (MUDC).
- Experiments involved varying bile acid inflow rates and supplementing with excess taurine.
- Bile flow and bile acid secretion were measured to assess cholestasis and protective effects.
Main Results:
- TUDC completely abolished TLC-induced cholestasis and increased bile flow and secretion.
- UDC provided protection at lower inflow rates, but this effect diminished significantly at higher rates.
- MUDC, a poorly taurine-conjugated derivative, offered minimal protection against TLC-induced cholestasis, even with added taurine.
Conclusions:
- Taurine conjugation of UDC is essential for its potent anticholestatic effect against TLC-induced cholestasis.
- UDC's protective efficacy is dependent on inflow rates and its degree of taurine conjugation.
- Taurine-conjugated UDC may be a more effective therapeutic agent for cholestatic liver diseases, especially where taurine metabolism is impaired.